体外膜氧合转运团队对严重急性呼吸衰竭患者的ECMO置入与转运:对其结局有何影响?
该回顾性单中心研究比较了2008至2012年间157例VV-ECMO置入患者中,由移动ECMO转运团队(MERT)置入并转运的118例(75%)与本院ICU现场置入患者的适应证、特征及结局,发现两组ICU死亡率(46.6% vs 53.8%,P=.5)和ECMO相关并发症率(53.4% vs 53.8%,P=1.0)相当,多变量分析显示MERT置入与ICU死亡率无关(OR 1.1,95%CI 0.4-2.7,P=.85),支持该策略用于管理严重急性呼吸衰竭患者。
要点
- MERT为118例(75%)难治性急性呼吸衰竭患者置入VV-ECMO并转运至ECMO转诊中心。
- MERT置入组与现场置入组ICU死亡率相当(46.6% vs 53.8%,P=.5)。
- MERT置入组与现场置入组ECMO相关并发症率相当(53.4% vs 53.8%,P=1.0)。
核心结论
- 经MERT置入VV-ECMO并转运至ECMO转诊中心的患者,其ICU死亡率和ECMO相关并发症与同一团队现场置入者相当,支持该策略用于管理严重急性呼吸衰竭患者。
研究设计与样本
- 回顾性单中心研究,纳入2008至2012年间157例VV-ECMO置入患者,比较MERT置入并转运者与本院ICU现场置入者的适应证、特征及结局。
主要发现
- 157例VV-ECMO置入中,MERT为118例(75%)难治性急性呼吸衰竭患者置入,其中位动脉血氧分压/吸入氧浓度比为58(四分位距50-73)。
- 急性呼吸衰竭伴严重多器官衰竭,中位简化急性生理评分II为71(61-81),中位序贯器官衰竭评分为14(10-16),82%的患者使用正性肌力药。
- 所有患者经地面救护车转运,中位距离15(6-25)km,中位转运时间35(25-35)分钟,转运期间未发生重大ECMO系统相关事件。
- MERT置入组与现场置入组ICU死亡率相当(46.6% vs 53.8%,P=.5),ECMO相关并发症率亦相当(53.4% vs 53.8%,P=1.0)。
- 多变量分析显示,MERT置入ECMO与ICU死亡率无关(比值比1.1;95%置信区间0.4-2.7;P=.85)。
临床怎么用
- 作者认为,对于严重急性呼吸衰竭患者,由MERT置入VV-ECMO并转运至ECMO转诊中心的策略得到支持。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Mobile extracorporeal membrane oxygenation (ECMO) retrieval teams (MERTs) assure ECMO implantation and under-ECMO retrieval of patients with most severe acute respiratory failure (ARF) to experienced ECMO centers. Although described as feasible, mobile ECMO has only been poorly evaluated in comparison with on-site implantation. This study was undertaken to compare the indications, characteristics, and outcomes of MERT-implanted patients with venovenous (VV)-ECMO versus those implanted on site in our intensive care unit (ICU). METHODS: Retrospective, single-center study. RESULTS: Among 157 VV-ECMO implantations from 2008 to 2012, the MERT hooked up 118 (75%) patients with refractory ARF, as reflected by their median partial pressure of O2 in arterial blood/fraction of inspired oxygen of 58 (interquartile range, 50-73). ARF was accompanied by severe multiorgan failure, with a median Simplified Acute Physiology Score-II of 71 (61-81), median Sequential Organ Failure Assessment score of 14 (10-16), and with 82% of the patients receiving inotropes. All patients were transported by ground ambulance: median distance was 15 (6-25) km, and median transport time was 35 (25-35) minutes, during which no major ECMO system-related event occurred. For the MERT- and on-site-implanted groups, ICU mortality was comparable (46.6% vs 53.8%, respectively, P = .5), as were ECMO-related complication rates (53.4% of MERT vs 53.8% of on-site-implanted groups, P = 1.0). According to multivariable analysis, MERT ECMO implantation was not associated with ICU mortality (odds ratio, 1.1; 95% confidence interval, 0.4-2.7; P = .85). CONCLUSIONS: ICU mortality and ECMO-related complications of patients with MERT-implanted VV-ECMO who were transferred to our ECMO referral center were comparable with those implanted on site by the same team, thereby supporting this strategy to manage patients with severe ARF.
引用
- Bréchot N, Mastroianni C, Schmidt M, et al. Retrieval of severe acute respiratory failure patients on extracorporeal membrane oxygenation: Any impact on their outcomes? J Thorac Cardiovasc Surg. 2017. PMID: 29246547. doi:10.1016/j.jtcvs.2017.10.084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。